BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 31

• BioMidwest

  PharMEDium Issues Voluntary Nationwide Recall Sterile Preparations Compounded With A Single Recalled Lot Of Fresenius Kabi Sensorcaine-MPF (Bupivacaine Hcl) Due To The Presence Of Glass Particulate Matter

  May 9, 2016

   · 

  2 min read
• Despite Investor Pressure, GlaxoSmithKline is Not Considering a Breakup

  May 9, 2016

   · 

  1 min read
• Business

  AMRI Appoints Louis Yu, Ph.D., As Senior Vice President, Quality And Compliance

  May 9, 2016

   · 

  2 min read
• The Lancet Oncology Publishes Head-To-Head Study Comparing First And Second Generation Targeted Therapies In Treatment Of EGFR-Mutation Positive Non-Small Cell Lung Cancer

  May 9, 2016

   · 

  8 min read
• Biotech Beach

  American Urological Association Release: Studies Demonstrate Protective Effects Of Testosterone In Hypogonadal Men

  May 9, 2016

   · 

  4 min read
• Sophiris Bio To Raise Approximately $5 Million Through At-the-Market Offering

  May 9, 2016

   · 

  3 min read
• Drug Development

  AbbVie Release: U.S. FDA Expands IMBRUVICA (Ibrutinib) Label To Include Overall Survival Data In Previously Untreated Chronic Lymphocytic Leukemia (CLL) And New Indication For Small Lymphocytic Lymphoma (SLL) Patients

  May 9, 2016

   · 

  14 min read
• Genetown

  Boston Scientific Announces Positive Long-Term Outcomes For S-ICD System In The EFFORTLESS Study

  May 9, 2016

   · 

  5 min read
• Pharm Country

  NYU Langone Medical Center Release: Study Suggests Testosterone Therapy Does Not Raise Risk Of Aggressive Prostate Cancer

  May 9, 2016

   · 

  4 min read
• Biotech Beach

  American Urological Association Release: Study Suggests Chemotherapy After Radical Prostatectomy May Benefit Men Who Are At High Risk For Relapse

  May 9, 2016

   · 

  3 min read